Bristol-Myers Squibb Company Ce (CELG-RI) Financials

CELG-RI Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 86.5 billion 66.4 billion
Dec. 31, 2025 90.0 billion 71.5 billion
Sept. 30, 2025 96.9 billion 78.3 billion
June 30, 2025 94.7 billion 77.2 billion

CELG-RI Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 757.0 million 146.0 million
Dec. 31, 2025 1.6 billion ?
Sept. 30, 2025 6.0 billion 139.0 million
June 30, 2025 3.6 billion 137.0 million

CELG-RI Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 2.7 billion
Dec. 31, 2025 1.1 billion
Sept. 30, 2025 2.2 billion
June 30, 2025 1.3 billion

CELG-RI Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 10.5 billion 42.2 billion 1.8 billion
Dec. 31, 2025 10.7 billion 44.7 billion 1.8 billion
Sept. 30, 2025 16.5 billion 44.5 billion 1.8 billion
June 30, 2025 13.6 billion 44.5 billion 1.6 billion

CELG-RI Shares Outstanding

No data available :(

CELG-RI Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 347.0 million 2.2 billion 1.6 billion -
Dec. 31, 2025 370.0 million 2.6 billion 2.1 billion -
Sept. 30, 2025 320.0 million 2.4 billion 1.8 billion -
June 30, 2025 361.0 million 2.3 billion 1.7 billion -

CELG-RI Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 11.5 billion 3.4 billion
Dec. 31, 2025 12.5 billion 4.2 billion
Sept. 30, 2025 12.2 billion 4.2 billion
June 30, 2025 12.3 billion 4.2 billion

CELG-RI Revenue by Segment
Graph available only for paid members. Upgrade to see it.

CELG-RI

Price: $0.10

52 week price:
0.09
0.12

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - General

Market Capitalization: 181.7 million

Links: